Genetic polymorphisms for estimating risk of atrial fibrillation: A literature-based meta-analysis

Journal of Internal Medicine

Volumn 272, Issue 6, 2012, Pages 573-582

  Smith, J G ^a,b   Almgren, P ^a   Engstrom G ^a   Hedblad, B ^a   Platonov, P G ^a   Newton Cheh, C ^b,c   Melander, O ^a  

^a LUND UNIVERSITY   (Sweden)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atrial fibrillation; Genetics; Genome wide association studies; Meta analysis; Prediction; Single nucleotide polymorphisms

Indexed keywords

AFRICAN AMERICAN; ARTICLE; ASIAN; CARDIOVASCULAR RISK; CHROMOSOME 1Q; CHROMOSOME 4Q; GENE; GENETIC ASSOCIATION; GENOME; GJA5 GENE; HEART ATRIUM FIBRILLATION; HUMAN; IL6R GENE; KCNH2 GENE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 84869878184     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02563.x     Document Type: Article

References (35)

1. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009; 461: 724-6.
2. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 2010; 303: 648-56.
3. Ripatti S, Tikkanen E, Orho-Melander M et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010; 376: 1393-400.
4. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009; 150: 65-72.
5. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159: 882-90.
6. Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-7.
7. Benjamin EJ, Rice KM, Arking DE et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41: 879-81.
8. Gudbjartsson DF, Holm H, Gretarsdottir S et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009; 41: 876-8.
9. Ellinor PT, Lunetta KL, Glazer NL et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010; 42: 240-4.
10. Sinner MF, Pfeufer A, Akyol M et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J 2008; 29: 907-14.
11. Fox CS, Parise H, D'Agostino Sr RB et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291: 2851-5.
12. Arnar DO, Thorvaldsson S, Manolio TA et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006; 27: 708-12.
13. Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet 2005; 118: 179-84.
14. Schnabel RB, Kerr KF, Lubitz SA et al. Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet 2011; 4: 557-64.
15. Wirka RC, Gore S, Van Wagoner DR et al. A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2011; 4: 87-93.
16. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
20. Smith JG, Newton-Cheh C, Almgren P, Melander O, Platonov PG. Genetic polymorphisms for estimating risk of atrial fibrillation in the general population: a prospective study. Arch Intern Med 2012; 172: 742-4.
21. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-23.
22. Schwarz GE. Estimating the dimension of a model. Ann Stat 1978; 6: 461-4.
23. Kääb S, Darbar D, van Noord C et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009; 30: 813-9.
24. Viviani Anselmi C, Novelli V, Roncarati R et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population. Heart 2008; 94: 1394-6.
25. Sinner MF, Lubitz SA, Pfeufer A et al. Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm 2011; 8: 403-9.
26. Shi L, Li C, Wang C et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet 2009; 126: 843-9.
27. Lee KT, Yeh HY, Tung CP et al. Association of rs2200733 but not rs10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population. Cardiology 2010; 116: 151-6.
28. Li C, Wang F, Yang Y et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet 2011; 129: 239-46.
29. Delaney JT, Jeff JM, Brown NJ et al. Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans. PLoS ONE 2012; 7: e32338.
30. Lasky-Su J, Lyon HN, Emilsson V et al. On the replication of genetic associations: timing can be everything!Am J Hum Genet 2008; 82: 849-58.
31. Lubitz SA, Sinner MF, Lunetta KL et al. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010; 122: 976-84.
32. Arnar DO, Holm H, Gudbjartsson DF. Predicting atrial fibrillation. Lancet 2009; 373: 1523.
33. Ackerman MJ, Priori SG, Willems S et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011; 13: 1077-109.
34. Pfeufer A, van Noord C, Marciante KD et al. Genome-wide association study of PR interval. Nat Genet 2010; 42: 153-9.
35. Ellinor PT, Lunetta KL, Albert CM et al. Meta-analysis identifies six new loci for atrial fibrillation. Nat Genet 2012; 44: 670-5.